Abstract

Advances in non-linear imaging combined with new generations of ultrasound contrast agents have broadened and improved the applications of sonography in general. New guidelines to the use of this novel technique from the European Federation of Societies of Ultrasound in Medicine and Biology (EFSUMB) will support its dissemination in the wider clinical practice. The effective impact of contrast-enhanced ultrasonography has been more predominant in liver imaging with respect to detection and characterization of focal hepatic lesions. Whilst it is not regarded as competing with contrast-enhanced CT and MRI, there are specific clinical niches where its potential impact and utilization are more likely to be universal.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.